Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5 + B cells

Immunology

Volumn 134, Issue 4, 2011, Pages 419-433

  Biswas, Subhabrata ^a,b   Chang, Hong ^a,b,d   Sarkis, Phuong T N ^a,b   Fikrig, Erol ^c   Zhu, Quan ^a,b   Marasco, Wayne A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

BLT; HIVgp140; Humanized mice; IC31; West Nile virus envelope

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 7; WEST NILE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG RESPONSE; ENGRAFTMENT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; SEROCONVERSION; SINGLE DRUG DOSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD5; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL DIFFERENTIATION; CHIMERA; FETAL TISSUE TRANSPLANTATION; GENE PRODUCTS, ENV; HIV-1; HUMANS; IMMUNITY, HUMORAL; IMMUNIZATION; LIVER; LIVER TRANSPLANTATION; MICE; MICE, SCID; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; THYMUS GLAND; VACCINES; WEST NILE VIRUS;

EID: 80355124399     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03501.x     Document Type: Article

References (50)

1. Manz MG, Di Santo JP. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol 2009; 10:1039-42.
2. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7:118-30.
3. Shultz LD, Lyons BL, Burzenski LM et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R γ null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174:6477-89.
4. Ishikawa F, Yasukawa M, Lyons B et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 2005; 106:1565-73.
5. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304:104-7.
6. -/- mice. J Virol 2007; 81:2700-12.
7. Watanabe S, Ohta S, Yajima M et al. Humanized NOD/SCID/IL2Rγ(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007; 81:13259-64.
8. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rγnull mice. PLoS ONE 2009; 4:e7251.
9. -/- mice. Proc Natl Acad Sci U S A 2006; 103:15951-6.
10. -/- (RAG-hu) mice. Virology 2007; 369:143-52.
11. -/-, and C.B-17-scid/bg immunodeficient mice. Hum Immunol 2009; 70:790-802.
12. Watanabe Y, Takahashi T, Okajima A et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γc(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009; 21:843-58.
13. + cells. Exp Hematol 2003; 31:789-97.
14. + B lymphoid cells in NOD/SCID mice. Stem Cells 1999; 17:242-52.
15. Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS ONE 2008; 3:e3192.
16. -/- mice without affecting peripheral T cell homeostasis. J Immunol 2009; 183:7645-55.
17. + cell transplantation. Blood 2006; 108:487-92.
18. Melkus MW, Estes JD, Padgett-Thomas A et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006; 12:1316-22.
19. Tonomura N, Habiro K, Shimizu A, Sykes M, Yang YG. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008; 111:4293-6.
20. -/- (NSG) BLT mice. Virology 2011; 417:154-60.
21. + T cell depletion in humanized mice infected with HIV-1. J Exp Med 2007; 204:705-14.
22. Denton PW, Estes JD, Sun Z et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008; 5:e16.
23. Denton PW, Krisko JF, Powell DA et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS ONE 2010; 5:e8829.
24. Denton PW, Othieno F, Martinez-Torres F et al. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol 2011; 85:7582-93.
25. Kumar P, Ban HS, Kim SS et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008; 134:577-86.
26. Brainard DM, Seung E, Frahm N et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 2009; 83:7305-21.
27. Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, Torrealba J, Burlingham WJ. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rγnull mice. Hum Immunol 2010; 71:551-9.
28. Doria-Rose NA, Klein RM, Manion MM et al. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 2009; 83:188-99.
29. Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA. A recombinant envelope protein vaccine against West Nile virus. Vaccine 2005; 23:3915-24.
30. Olafsdottir TA, Lingnau K, Nagy E, Jonsdottir I. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice. Scand J Immunol 2009; 69:194-202.
31. Riedl K, Riedl R, von Gabain A, Nagy E, Lingnau K. The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice. Vaccine 2008; 26:3461-8.
32. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005; 26:347-62.
33. Hayakawa K, Hardy RR, Herzenberg LA. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985; 161:1554-68.
34. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76:1647-56.
35. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374-7.
36. Bower JF, Li Y, Wyatt R, Ross TM. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine 2006; 24:5442-51.
37. Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438:364-8.
38. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000; 21:204-6.
39. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci U S A 1995; 92:11249-53.
40. Cuss AK, Avery DT, Cannons JL, Yu LJ, Nichols KE, Shaw PJ, Tangye SG. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006; 176:1506-16.
41. + pre-naive B cell population. J Immunol 2009; 182:4116-26.
42. Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 2006; 18:547-55.
43. Veneri D, Franchini M, de Sabata D, Ledro S, Vella A, Ortolani R, Pizzolo G, Benedetti F. Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans. Blood Transfus 2008; 6:220-4.
44. Becker PD, Legrand N, van Geelen CM et al. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS ONE 2010; 5:e13137.
45. + B cells. J Exp Med 2008; 205:2033-42.
46. +CD70. J Exp Med 2011; 208:67-80.
47. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000; 1:433-40.
48. Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A 2009; 106:21783-8.
49. O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS ONE 2010; 5:e12009.
50. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-80.